Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress.

As expected, the nivolumab sample exposed to light showed a statistically highly significant decrease in the binding capacity of nivolumab to PD-1 ( Figure 6 ), falling to around 70% of that of the control sample ( Table 9 ).

also in 132,142 other papers